Assistant Professor, Psychiatry, Duke University School of Medicine
Psychiatry
Dr. Kishore Gadde, MD
|
|
Give Review
Kishore Gadde works in the field of Psychiatry. He researched medicine at Guntur Medical College NTR. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Kishore Gadde is also published. He has 44 publications published. The lastest publication: "Psychoneuroendocrinology and brain imaging in depression.' Kishore Gadde is registered with Medicare.
Publications
- Weight loss: slow and steady does not win the race.
- Obesity medications reduce total body weight by 3-9% compared with placebo, when combined with lifestyle changes.
- Combination phentermine/topiramate for obesity treatment in primary care: a review.
- Current pharmacotherapy for obesity: extrapolation of clinical trials data to practice.
- Weight loss treatment in obese adults.
- Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults.
- Zonisamide for weight reduction in obese adults: a 1-year randomized controlled trial.
- Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity.
- Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity.
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-con...
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP).
- Sexual functioning in obese adults enrolling in a weight loss study.
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a ran...
- Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methods.
- Sample size in obesity trials: patient perspective versus current practice.
- The effect of acute tryptophan depletion on emotional distraction and subsequent memory.
- Combination therapy for obesity and metabolic disease.
- Combination pharmaceutical therapies for obesity.
- Rational design of a combination medication for the treatment of obesity.
- Zonisamide prevents olanzapine-associated hyperphagia, weight gain, and elevated blood glucose in rats.
- Childhood socioeconomic status and serotonin transporter gene polymorphism enhance cardiovascular reactivity to mental stress.
- Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study.
- A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 d...
- Bupropion for weight reduction.
- Escitalopram treatment of trichotillomania.
- Cannabinoid-1 receptor antagonist, rimonabant, for management of obesity and related risks.
- Effect of rimonabant on weight and cardiometabolic risk factors.
- Bupropion treatment of olanzapine-associated weight gain: an open-label, prospective trial.
- Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment.
- Endocannabinoid receptor antagonists and other emerging pharma-cological strategies for weight reduction.
- Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial.
- Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression Trial.
- The use of aripiprazole in obsessive-compulsive Disorder: preliminary observations in 8 patients.
- Assessing patient beliefs in a clinical trial of Hypericum perforatum in Major depression.
- Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia.
- Zonisamide for weight loss in obese adults: a randomized controlled trial.
- Serotonin-related gene polymorphisms and central nervous system serotonin function.
- Bupropion SR vs. placebo for weight loss in obese patients with Depressive symptoms.
- Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial.
- Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women.
- Central nervous system serotonin function and cardiovascular responses to stress.
- Psychoneuroendocrinology and brain imaging in depression.
- Diltiazem effect on carbamazepine levels in manic depression.
Schools
Guntur Medical College Ntr University Of Health Sciences
Clinical Center At The Nih
University Hospital Of Cleveland
Western Mo Mntl Health Center
Procedures Preformed
- Psychiatric Evaluation
- Psychotherapy and Psychophysiological Therapy (incl. Biofeedback)
Conditions Treated
- Adjustment Disorder
- Major Depressive Disorder
Doctors Specialties
- Psychiatry
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
National Institutes of Health Clinical Center -
Case Western Reserve University - University Hospitals -
Guntur Medical College NTR
Hospital
-
Duke University Hospital
Drug Facts
| NPI NUMBER | 1003979873 | |
| NPPES Provider LastName | GADDE | |
| NPPES Provider FirstName | KISHORE | |
| NPPES Provider ZIPCode | 277100001 | |
| NPPES Provider State | NC | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 218.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1003979873 |
| Last Name Of The Provider | GADDE |
| First Name Of The Provider | KISHORE |
| View All |
Similar Doctors
|
|
Dr. Chunsheng J. Wang, MD |
|
|
Dr. Gregory M. Weiss, MD |
|
|
Dr. Lothar M. Varady, MD |
|
|
Dr. Mohammad O. Aslam, MD |
|
|
Dr. Mahmoud N. Malayeri, MD |
|
|
Dr. Linda B. Snyder, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Taly Drimer-Kagan, MD |